skip to main content
Idioma:
Resultados 1 2 3 4 next page
Mostrar Somente
Refinado por: Nome da Publicação: Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement

Bratslavsky, Gennady ; Mendhiratta, Neil ; Daneshvar, Michael ; Brugarolas, James ; Ball, Mark W. ; Metwalli, Adam ; Nathanson, Katherine L. ; Pierorazio, Phillip M. ; Boris, Ronald S. ; Singer, Eric A. ; Carlo, Maria I. ; Daly, Mary B. ; Henske, Elizabeth P. ; Hyatt, Colette ; Middleton, Lindsay ; Morris, Gloria ; Jeong, Anhyo ; Narayan, Vivek ; Rathmell, W. Kimryn ; Vaishampayan, Ulka ; Lee, Bruce H. ; Battle, Dena ; Hall, Michael J. ; Hafez, Khaled ; Jewett, Michael A. S. ; Karamboulas, Christina ; Pal, Sumanta K. ; Hakimi, A. Ari ; Kutikov, Alexander ; Iliopoulos, Othon ; Linehan, W. Marston ; Jonasch, Eric ; Srinivasan, Ramaprasad ; Shuch, Brian

Cancer, 2021-11, Vol.127 (21), p.3957-3966 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center
Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increasing referral of at‐risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center

Arun, Banu K. ; Peterson, Susan K. ; Sweeney, Lilian E. ; Bluebond, Rachel D. ; Tidwell, Rebecca S. S. ; Makhnoon, Sukh ; Kushwaha, Anne C.

Cancer, 2022-01, Vol.128 (1), p.94-102 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma
Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma

Kopp, Ryan P. ; Stratton, Kelly L. ; Glogowski, Emily ; Schrader, Kasmintan A. ; Rau‐Murthy, Rohini ; Russo, Paul ; Coleman, Jonathan A. ; Offit, Kenneth

Cancer, 2017-07, Vol.123 (13), p.2452-2458 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Bellone, Stefania ; Roque, Dana M. ; Siegel, Eric R. ; Buza, Natalia ; Hui, Pei ; Bonazzoli, Elena ; Guglielmi, Adele ; Zammataro, Luca ; Nagarkatti, Nupur ; Zaidi, Samir ; Lee, Jungsoo ; Silasi, Dan‐Arin ; Huang, Gloria S. ; Andikyan, Vaagn ; Damast, Shari ; Clark, Mitchell ; Azodi, Masoud ; Schwartz, Peter E. ; Tymon‐Rosario, Joan R. ; Harold, Justin A. ; Mauricio, Dennis ; Zeybek, Burak ; Menderes, Gulden ; Altwerger, Gary ; Ratner, Elena ; Alexandrov, Ludmil B. ; Iwasaki, Akiko ; Kong, Yong ; Song, Eric ; Dong, Weilai ; Elvin, Julia A. ; Choi, Jungmin ; Santin, Alessandro D.

Cancer, 2022-03, Vol.128 (6), p.1206-1218 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
5
Genetic testing for Lynch syndrome in the province of Ontario
Genetic testing for Lynch syndrome in the province of Ontario
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic testing for Lynch syndrome in the province of Ontario

Wang, Marina ; Aldubayan, Saud ; Connor, Ashton A. ; Wong, Beatrix ; Mcnamara, Kate ; Khan, Tahsin ; Semotiuk, Kara ; Khalouei, Sam ; Holter, Spring ; Aronson, Melyssa ; Cohen, Zane ; Gallinger, Steve ; Charames, George ; Pollett, Aaron ; Lerner‐Ellis, Jordan

Cancer, 2016-06, Vol.122 (11), p.1672-1679 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
6
Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas
Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

Complex epidermal growth factor receptor mutations and their responses to tyrosine kinase inhibitors in previously untreated advanced lung adenocarcinomas

Zhang, Bo ; Wang, Shuyuan ; Qian, Jie ; Yang, Wenjia ; Qian, Fangfei ; Lu, Jun ; Zhang, Yanwei ; Qiao, Rong ; Han, Baohui

Cancer, 2018-06, Vol.124 (11), p.2399-2406 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
Molecular testing for thyroid nodules: Review and current state
Molecular testing for thyroid nodules: Review and current state
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular testing for thyroid nodules: Review and current state

Roth, Mara Y. ; Witt, Robert L. ; Steward, David L.

Cancer, 2018-03, Vol.124 (5), p.888-898 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor–mutant lung cancers
MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor–mutant lung cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor–mutant lung cancers

Gu, Jiajia ; Yao, Weilong ; Shi, Puyu ; Zhang, Guojing ; Owonikoko, Taofeek K. ; Ramalingam, Suresh S. ; Sun, Shi‐Yong

Cancer, 2020-08, Vol.126 (16), p.3788-3799 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cost‐effectiveness of epidermal growth factor receptor mutation testing and first‐line treatment with gefitinib for patients with advanced adenocarcinoma of the lung

de Lima Lopes, Gilberto ; Segel, Joel E. ; Tan, Daniel S. W. ; Do, Young K. ; Mok, Tony ; Finkelstein, Eric A.

Cancer, 2012-02, Vol.118 (4), p.1032-1039 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
10
Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
Material Type:
Artigo 		Adicionar ao Meu Espaço

Twice weekly pulse and daily continuous‐dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases

Arbour, Kathryn C. ; Kris, Mark G. ; Riely, Gregory J. ; Ni, Ai ; Beal, Kathryn ; Daras, Mariza ; Hayes, Sara A. ; Young, Robert J. ; Rodriguez, Christopher R. ; Ahn, Linda ; Pao, William ; Yu, Helena A.

Cancer, 2018-01, Vol.124 (1), p.105-109 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (35)
  2. Revistas revisadas por pares (35)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.